Gerard D. Schellenberg

43.3k total citations · 5 hit papers
214 papers, 16.9k citations indexed

About

Gerard D. Schellenberg is a scholar working on Physiology, Molecular Biology and Genetics. According to data from OpenAlex, Gerard D. Schellenberg has authored 214 papers receiving a total of 16.9k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Physiology, 112 papers in Molecular Biology and 63 papers in Genetics. Recurrent topics in Gerard D. Schellenberg's work include Alzheimer's disease research and treatments (118 papers), Bioinformatics and Genomic Networks (38 papers) and Genetic Associations and Epidemiology (31 papers). Gerard D. Schellenberg is often cited by papers focused on Alzheimer's disease research and treatments (118 papers), Bioinformatics and Genomic Networks (38 papers) and Genetic Associations and Epidemiology (31 papers). Gerard D. Schellenberg collaborates with scholars based in United States, Japan and Canada. Gerard D. Schellenberg's co-authors include Ellen M. Wijsman, Thomas D. Bird, Parvoneh Poorkaj, Ian D’Souza, Ellen Nemens, Chang-En Yu, Murray A. Raskind, Junko Oshima, Ying‐Hui Fu and George M. Martin and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Nucleic Acids Research.

In The Last Decade

Gerard D. Schellenberg

211 papers receiving 16.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Candidate Gene for the Chromosome 1 Familial Alzheimer's Disease Locus

1995 2.0k citations Junko Oshima, Chang-En Yu et al. profile →
Positional Cloning of the Werner's Syndrome Gene

1996 1.4k citations Chang-En Yu, Junko Oshima et al. profile →
Tau is a candidate gene for chromosome 17 frontotemporal dementia

1998 1.1k citations Thomas D. Bird, Ellen M. Wijsman et al. Annals of Neurology profile →
Genetic Linkage Evidence for a Familial Alzheimer's Disease Locus on Chromosome 14

1992 683 citations Gerard D. Schellenberg, Thomas D. Bird et al. profile →
Dementia and Alzheimer Disease Incidence

2002 563 citations Walter A. Kukull, Roger Higdon et al. Archives of Neurology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Gerard D. Schellenberg United States	65	9.5k	7.7k	3.0k	2.6k	2.4k	214	16.9k
Thomas D. Bird United States	62	10.4k 1.1×	7.5k 1.0×	3.7k 1.2×	3.4k 1.3×	3.5k 1.5×	201	17.3k
Margaret A. Pericak‐Vance United States	63	4.8k 0.5×	7.0k 0.9×	2.9k 1.0×	2.4k 0.9×	2.0k 0.8×	340	18.4k
Thomas Wısnıewskı United States	76	11.7k 1.2×	8.8k 1.1×	1.8k 0.6×	3.4k 1.3×	4.0k 1.7×	389	20.5k
Lars Lannfelt Sweden	75	14.2k 1.5×	8.4k 1.1×	2.2k 0.8×	2.9k 1.1×	3.1k 1.3×	312	20.7k
Sam Gandy United States	74	13.2k 1.4×	8.1k 1.1×	2.2k 0.7×	3.7k 1.4×	2.8k 1.2×	292	21.5k
D. E. Schmechel United States	28	13.2k 1.4×	8.2k 1.1×	1.9k 0.6×	3.6k 1.4×	2.7k 1.1×	39	21.1k
Michael Mullan United States	64	7.9k 0.8×	5.5k 0.7×	2.2k 0.7×	2.1k 0.8×	3.8k 1.6×	319	15.3k
Warren J. Strittmatter United States	53	14.8k 1.6×	10.7k 1.4×	2.6k 0.9×	5.2k 2.0×	2.9k 1.2×	107	25.3k
Lars Bertram Germany	48	6.1k 0.6×	5.3k 0.7×	1.1k 0.4×	2.0k 0.8×	1.5k 0.6×	172	13.0k
André Delacourte France	66	10.7k 1.1×	7.1k 0.9×	2.9k 1.0×	3.7k 1.4×	3.2k 1.4×	201	18.1k

Countries citing papers authored by Gerard D. Schellenberg

Since Specialization

Citations

This map shows the geographic impact of Gerard D. Schellenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerard D. Schellenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerard D. Schellenberg more than expected).

Fields of papers citing papers by Gerard D. Schellenberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerard D. Schellenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerard D. Schellenberg. The network helps show where Gerard D. Schellenberg may publish in the future.

Co-authorship network of co-authors of Gerard D. Schellenberg

This figure shows the co-authorship network connecting the top 25 collaborators of Gerard D. Schellenberg. A scholar is included among the top collaborators of Gerard D. Schellenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerard D. Schellenberg. Gerard D. Schellenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

O’Neill, Nicholas K., Nuzulul Kurniansyah, Congcong Zhu, et al.. (2025). Multi-omic derived cell-type specific Alzheimer disease polygenic risk scores. Neurobiology of Aging. 155. 44–52.

Xu, Hong, Qi Qiu, Peng Hu, et al.. (2024). MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons. Acta Neuropathologica. 147(1). 55–55. 3 indexed citations

Vance, Jeffery M., Lindsay A. Farrer, Yadong Huang, et al.. (2024). Report of the APOE4 National Institute on Aging/Alzheimer Disease Sequencing Project Consortium Working Group: Reducing APOE4 in Carriers is a Therapeutic Goal for Alzheimer's Disease. Annals of Neurology. 95(4). 625–634. 21 indexed citations

Naj, Adam C., Penelope Benchek, Logan Dumitrescu, et al.. (2023). A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease. Alzheimer s & Dementia. 19(11). 4886–4895. 5 indexed citations

Ayodele, Temitope, María Victoria Fernández, Joseph Bradley, et al.. (2023). The Early‐Onset Alzheimer's Disease Whole‐Genome Sequencing Project: Study design and methodology. Alzheimer s & Dementia. 19(9). 4187–4195. 2 indexed citations

Greenfest‐Allen, Emily, Otto Valladares, Pavel P. Kuksa, et al.. (2023). NIAGADS Alzheimer's GenomicsDB: A resource for exploring Alzheimer's disease genetic and genomic knowledge. Alzheimer s & Dementia. 20(2). 1123–1136. 11 indexed citations

Alquézar, Carolina, Kathleen M. Schoch, Ethan G. Geier, et al.. (2021). TSC1 loss increases risk for tauopathy by inducing tau acetylation and preventing tau clearance via chaperone-mediated autophagy. Science Advances. 7(45). eabg3897–eabg3897. 26 indexed citations

Vergouw, Leonie J.M., Shamiram Melhem, Laura Donker Kaat, et al.. (2020). LRP10 variants in progressive supranuclear palsy. Neurobiology of Aging. 94. 311.e5–311.e10. 5 indexed citations

Leung, Yuk Yee, Otto Valladares, Yi‐Fan Chou, et al.. (2018). VCPA: genomic variant calling pipeline and data management tool for Alzheimer’s Disease Sequencing Project. Bioinformatics. 35(10). 1768–1770. 20 indexed citations

10.

Belitskaya‐Lévy, Ilana, Maurice W. Dysken, Peter Guarino, et al.. (2018). Impact of apolipoprotein E genotypes on vitamin E and memantine treatment outcomes in Alzheimer's disease. Alzheimer s & Dementia Translational Research & Clinical Interventions. 4(1). 344–349. 9 indexed citations

11.

Reitz, Christiane, Giuseppe Tosto, Badri N. Vardarajan, et al.. (2013). Independent and epistatic effects of variants in VPS10-d receptors on Alzheimer disease risk and processing of the amyloid precursor protein (APP). Translational Psychiatry. 3(5). e256–e256. 58 indexed citations

12.

Guthrie, Chris R., Gerard D. Schellenberg, & Brian C. Kraemer. (2009). SUT-2 potentiates tau-induced neurotoxicity in Caenorhabditis elegans. Human Molecular Genetics. 18(10). 1825–1838. 86 indexed citations

13.

Leverenz, James B., Chang Yu, Thomas J. Montine, et al.. (2007). A novel progranulin mutation associated with variable clinical presentation and tau, TDP43 and alpha-synuclein pathology. Brain. 130(5). 1360–1374. 96 indexed citations

14.

Kraemer, Brian C., et al.. (2006). Molecular pathways that influence human tau-induced pathology in Caenorhabditis elegans. Human Molecular Genetics. 15(9). 1483–1496. 112 indexed citations

15.

D’Souza, Ian & Gerard D. Schellenberg. (2005). Arginine/Serine-rich Protein Interaction Domain-dependent Modulation of a Tau Exon 10 Splicing Enhancer. Journal of Biological Chemistry. 281(5). 2460–2469. 42 indexed citations

16.

Li, Ge, Monique M. Cherrier, Debby W. Tsuang, et al.. (2005). Salivary cortisol and memory function in human aging. Neurobiology of Aging. 27(11). 1705–1714. 100 indexed citations

17.

Kukull, Walter A., Roger Higdon, James D. Bowen, et al.. (2002). Dementia and Alzheimer Disease Incidence. Archives of Neurology. 59(11). 1737–1737. 563 indexed citations breakdown →

18.

Blander, Gil, Jonathan Kipnis, Juan Fernando Martínez-Leal, et al.. (1999). Physical and Functional Interaction between p53 and the Werner's Syndrome Protein. Journal of Biological Chemistry. 274(41). 29463–29469. 147 indexed citations

19.

Oshima, Junko, Chang-En Yu, Michael Boehnke, et al.. (1994). Integrated Mapping Analysis of the Werner Syndrome Region of Chromosome 8. Genomics. 23(1). 100–113. 21 indexed citations

20.

Nakura, Jun, Tetsuro Miki, Keiko Nagano, et al.. (1993). Close Linkage of the Gene for Werner’s Syndrome to ANK1 and D8S87 on the Short Arm of Chromosome 8. Gerontology. 39(1). 11–15. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact